Daniel Nadler is the founder of OpenEvidence, an ad-supported AI search platform for medical literature and clinical guidelines. Recent coverage reports that OpenEvidence reached a $15 billion valuation, is used by nearly two-thirds of US doctors, and processed over 42 million prompts last month. The company also partnered with Anthropic and Penn Medicine to offer free AI clinical decision support in about 100 low- and middle-income countries.
OpenEvidence hits $15B valuation, used by nearly two-thirds of US doctorsAd-supported AI search platform OpenEvidence has reached a $15 billion valuation, with nearly two-thirds of US doctors using it to consult medical literature and clinical guidelines for patient care. The company said it processed over 42 million prompts last month, and its founder calls it the first viral consumer internet app in healthcare.
OpenEvidence partners with Anthropic, Penn Medicine to expand AI in Africa and AsiaOpenEvidence is partnering with Anthropic and Penn Medicine to offer free AI-powered clinical decision support in 100 low- and middle-income countries across Africa and Asia. Anthropic provides Claude Credits, engineers, and funding; OpenEvidence tailors the platform to local medical guidelines.
Anthropic, OpenEvidence partner to bring medical AI worldwideAnthropic and OpenEvidence are partnering to provide free AI-powered clinical decision support in about 100 low- and middle-income countries, including Uganda and Angola. OpenEvidence was consulted 42 million times by US clinicians in August alone.
The A.I. Daily